Sanjivani Paranteral Ltd vs Strides Pharma Science Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Sanjivani Paranteral Ltd is ₹ 132.6 as of 18 May 14:20 . The P/E Ratio of Sanjivani Paranteral Ltd changed from 28.4 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Strides Pharma Science Ltd changed from 1.7 on March 2025 to 0 on March 2023 . This represents a CAGR of -100.00% over 4 years The Market Cap of Sanjivani Paranteral Ltd changed from ₹ 175.32 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Strides Pharma Science Ltd changed from ₹ 7192 crore on March 2024 to ₹ 2584 crore on March 2023 . This represents a CAGR of -18.51% over 5 years The revenue of Sanjivani Paranteral Ltd for the Mar '26 is ₹ 13.81 crore as compare to the Dec '25 revenue of ₹ 22.36 crore. This represent the decline of -38.24% The revenue of Strides Pharma Science Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1301 crore. This represent the decline of -100% The ebitda of Sanjivani Paranteral Ltd for the Mar '26 is ₹ 2.17 crore as compare to the Dec '25 ebitda of ₹ 4.13 crore. This represent the decline of -47.46% The ebitda of Strides Pharma Science Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 339.48 crore. This represent the decline of -100% The net profit of Sanjivani Paranteral Ltd changed from ₹ 1.71 crore to ₹ 0.55 crore over 8 quarters. This represents a CAGR of -43.29% The net profit of Strides Pharma Science Ltd changed from ₹ 3349 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Sanjivani Paranteral Ltd changed from 7.33 % on March 2025 to 7.33 % on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Strides Pharma Science Ltd changed from 28.66 % on March 2021 to 1.28 % on March 2025 . This represents a CAGR of -46.30% over 5 years .

About Sanjivani Paranteral Ltd

Sanjivani Paranteral Limited is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades.
The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun. Incorporated as a Public Limited Company in October, 1994, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry.
The Company is involved in the manufacturing of pharmaceutical medicines.
Its products includes oral solids, small volume parenteral and sterile powder formulations. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative.

About Strides Pharma Science Ltd

Strides Pharma Science Limited was originally incorporated under the name 'Strides Arcolab Limited ' on June 28, 1990.
In FY 2016, Shasun Pharmaceuticals Limited merged with Strides Arcolab Limited forming a new identity 'Strides Shasun Limited', making it effective from 19 November, 2015 and name of the Company was changed to 'Strides Pharma Science Limited' from 'Strides Shasun Limited' effective on July 18, 2018. Strides Pharma Science is a global pharmaceutical company headquartered in Bengaluru, India.
The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic.
It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals.
Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids.

FAQs for the comparison of Sanjivani Paranteral Ltd and Strides Pharma Science Ltd

Which company has a larger market capitalization, Sanjivani Paranteral Ltd or Strides Pharma Science Ltd?

Market cap of Sanjivani Paranteral Ltd is 167 Cr while Market cap of Strides Pharma Science Ltd is 10,636 Cr

What are the key factors driving the stock performance of Sanjivani Paranteral Ltd and Strides Pharma Science Ltd?

The stock performance of Sanjivani Paranteral Ltd and Strides Pharma Science Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanjivani Paranteral Ltd and Strides Pharma Science Ltd?

As of May 18, 2026, the Sanjivani Paranteral Ltd stock price is INR ₹136.3. On the other hand, Strides Pharma Science Ltd stock price is INR ₹1154.0.

How do dividend payouts of Sanjivani Paranteral Ltd and Strides Pharma Science Ltd compare?

To compare the dividend payouts of Sanjivani Paranteral Ltd and Strides Pharma Science Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.